International records / OpenAlex research

Overpromotion of Drugs in International Product Package Inserts

A study of the drug-labelling information contained in international product package inserts (PPIs) available in Nigeria in comparison with similar information in the United States Physicians' Desk Reference (PDR) was undertaken, against a background of recently-improved drug control regulations in Nigeria. The findings indicate that most multinational pharmaceutical firms, especially through their affiliates and subsidiaries, overpromote their drugs for extra indications and with mention of fewer hazards in the PPIs, than in the PDR. For some drugs with known, medically-stringent indications …